Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Patent
1998-10-05
2000-06-27
Elliott, George C.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
435 6, 435 911, 435366, 536 231, 536 2431, 536 2433, 536245, C07H 2104, C12Q 168, C12N 1585
Patent
active
060805803
ABSTRACT:
Compositions and methods are provided for inhibiting the expression of human tumor necrosis factor-.alpha. (TNF-.alpha.). Antisense oligonucleotides targeted to nucleic acids encoding TNF-.alpha. are preferred. Methods of using these oligonucleotides for inhibition of TNF-.alpha. expression and for treatment of diseases, particularly inflammatory and autoimmune diseases, associated with overexpression of TNF-.alpha. are provided.
REFERENCES:
patent: 5650316 (1997-07-01), Aggarwal et al.
Branch, TIBS 23:45-50, Feb. 1998.
Flanagan et al, Nature Biotech. 17:48-52, Jan. 1999.
Crooke, from Antisense Research & Application, p1-50, 1998.
Lane et al., Int.J. Ober. Relat. Metab. Disord.: 20 Sppl 3 pS91-6, Mar. 1996.
Zou et al., Metabolism, 46(1) 114-8, Jan. 1997.
Trayhurn et al, FEBS Lett., 368(3) 488-90, Jul. 1995.
Uhlmann et al, Chem Rev., 90 (4) 543-584, Jun. 1990.
Kirchgessher et al, J. Clin Invest, 100(11) 2777-82, Dec. 1997.
Aggarwal et al., "Triple Helix-forming Oligodeoxyribonucleotides Targeted to the Human Tumor Necrosis Factor (TNF) Gene Inhibit TNF Production and Block the TNF-dependent Growth of Human Gliblastoma Tumor Cells", 1996, Cancer Res., 56, 5156-5164.
dHellencourt, "Inhibition of human TNF.alpha. and LT in Cell-free extracts and in cell culture by antisense oligonucleotides", 1996, Biochim, Biophys. Acta, 1317, 168-174.
Hartmann, "Oligodeoxynucleotides Enhance Lipopolysaccharide-Stimulated Synthesis of Tumor Necrosis Factor: Dependence on Phosphorothioate Modification and Reversal by Heparin", 1996, Mol. Med., 2, 429-438.
Hartmann, "Specific Suppression of Human Tumor Necrosis Factor-.alpha. Synthesis by Antisense Oligodeoxynucletides", 1996, Antisense Nucleic Acid Drug Devel., 6, 291-299.
Rojanasakul, "Antisense Inhibition of Silica-induced Tumor Necrosis Factor in Alveolar macrophanges", 1997, J. Biol.Chem., 272, 3910-3914.
Taylor et al., "In Vitro Efficacy of Morpholino-modified Antisense Oligomers Directed against Tumor Necrosis Factor-.alpha. mRNA", 1998, Antisense Nucleic Acid Drug Devel., 8, 199-205.
Taylor et al., "Effect of TNF-.alpha. Antisense Oligomers on Cytokine Production by Primary Murine Alveolar macrophages", 1996, J. Biol. Chem., 271, 17445-17452.
Tu et al., "Tetranucleotide GGGA Motif in Primary RNA Transcripts", 1998, J. Biol. Chem., 273, 25125-25131.
Baker Brenda F.
Bennett C. Frank
Butler Madeline M.
Shanahan, Jr. William R.
Elliott George C.
Isis Pharmaceuticals , Inc.
Schmidt Mary Melissa
LandOfFree
Antisense oligonucleotide modulation of tumor necrosis factor-.a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotide modulation of tumor necrosis factor-.a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide modulation of tumor necrosis factor-.a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1783447